OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion
Qiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, et al.
Science (2022) Vol. 378, Iss. 6621
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The role of extracellular vesicles in cancer
Raghu Kalluri, Kathleen M. McAndrews
Cell (2023) Vol. 186, Iss. 8, pp. 1610-1626
Closed Access | Times Cited: 298

Cancer hallmarks intersect with neuroscience in the tumor microenvironment
Douglas Hanahan, Michelle Monje
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 573-580
Open Access | Times Cited: 130

How chemokines organize the tumour microenvironment
Thorsten R. Mempel, Julia K. Lill, Lukas M. Altenburger
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 28-50
Closed Access | Times Cited: 95

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70

Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance
Hannah N. Bell, Weiping Zou
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 521-550
Closed Access | Times Cited: 22

Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1
W. Ren, Zilong Xu, Yating Chang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18

Crosstalk Between the Nervous System and Tumor Microenvironment: Functional Aspects and Potential Therapeutic Strategies
Lei Wang, Jingjing Ge, Huiqiong Han, et al.
Cancer Letters (2024) Vol. 594, pp. 216986-216986
Closed Access | Times Cited: 18

Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18

Recent advances in Prussian blue-based photothermal therapy in cancer treatment
Kaiyuan Tang, Xiao Li, Yanling Hu, et al.
Biomaterials Science (2023) Vol. 11, Iss. 13, pp. 4411-4429
Closed Access | Times Cited: 27

The tumor-intrinsic role of the m 6 A reader YTHDF2 in regulating immune evasion
Sai Jin Xiao, Shoubao Ma, Baofa Sun, et al.
Science Immunology (2024) Vol. 9, Iss. 95
Open Access | Times Cited: 13

Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11

Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth
Katelyn L. Donahue, Hannah R. Watkoske, Padma Kadiyala, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1964-1989
Open Access | Times Cited: 11

Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy
Yiwei Zhang, Yujun Zhang, Jingjing Song, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111876-111876
Closed Access | Times Cited: 9

Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9

Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment
Reza Mehdizadeh, Seyed Peyman Shariatpanahi, Bahram Goliaei, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12

Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer
Han Wang, Zhijun Zhou, Junchang Zhang, et al.
Cancer Letters (2023) Vol. 581, pp. 216498-216498
Closed Access | Times Cited: 11

DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression
Ya Wen, Xiwang Yang, Yifei Li, et al.
Oncogene (2024) Vol. 43, Iss. 29, pp. 2266-2278
Closed Access | Times Cited: 4

PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access

WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis
Weiliang Jiang, Bingjie Guan, Hongcheng Sun, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Deciphering the role of liquid-liquid phase separation in sarcoma: Implications for pathogenesis and treatment
Zehao Cheng, Hua Wang, Y M Zhang, et al.
Cancer Letters (2025) Vol. 616, pp. 217585-217585
Closed Access

Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression
Yunxiao Ge, Veronica Janson, Zigang Dong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189296-189296
Open Access

Page 1 - Next Page

Scroll to top